| Author | Herling, Carmen Diana | dc.contributor.author |
| Author | Klaumuenzer, Marion | dc.contributor.author |
| Author | Rocha, Cristiano Krings | dc.contributor.author |
| Author | Altmueller, Janine | dc.contributor.author |
| Author | Thiele, Holger | dc.contributor.author |
| Author | Bahlo, Jasmin | dc.contributor.author |
| Author | Kluth, Sandra | dc.contributor.author |
| Author | Crispatzu, Giuliano | dc.contributor.author |
| Author | Herling, Marco | dc.contributor.author |
| Author | Schiller, Joanna | dc.contributor.author |
| Author | Engelke, Anja | dc.contributor.author |
| Author | Tausch, Eugen | dc.contributor.author |
| Author | Döhner, Hartmut | dc.contributor.author |
| Author | Fischer, Kirsten | dc.contributor.author |
| Author | Goede, Valentin | dc.contributor.author |
| Author | Nuernberg, Peter | dc.contributor.author |
| Author | Reinhardt, Hans Christian | dc.contributor.author |
| Author | Stilgenbauer, Stephan | dc.contributor.author |
| Author | Hallek, Michael | dc.contributor.author |
| Author | Kreuzer, Karl-Anton | dc.contributor.author |
| Date of accession | 2017-12-13T14:46:37Z | dc.date.accessioned |
| Available in OPARU since | 2017-12-13T14:46:37Z | dc.date.available |
| Date of first publication | 2016 | dc.date.issued |
| Language | en | dc.language.iso |
| Publisher | Universität Ulm | dc.publisher |
| Keyword | chronic lymphocytic-leukemia | dc.subject |
| Keyword | identifies recurrent mutations | dc.subject |
| Keyword | chromosomal translocations | dc.subject |
| Keyword | genetic-characterization | dc.subject |
| Keyword | metaphase cytogenetics | dc.subject |
| Keyword | independent predictor | dc.subject |
| Keyword | genomic aberrations | dc.subject |
| Keyword | telomere length | dc.subject |
| Keyword | splicing factor | dc.subject |
| Keyword | poor-prognosis | dc.subject |
| Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
| Title | Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy | dc.title |
| Resource type | Wissenschaftlicher Artikel | dc.type |
| Institution | UKU. Klinik für Innere Medizin III | uulm.affiliationSpecific |
| DCMI Type | Text | uulm.typeDCMI |
| Category | Publikationsnachweise | uulm.category |
| DOI (external) | 10.1182/blood-2016-01-691550 | dc.identifier.doiExternal |
| Source - Title of source | Blood | source.title |
| Source - Place of publication | American Society of Hematology | source.publisher |
| Source - Volume | 128 | source.volume |
| Source - Issue | 3 | source.issue |
| Source - Year | 2016 | source.year |
| Source - From page | 395 | source.fromPage |
| Source - To page | 404 | source.toPage |
| Source - ISSN | 0006-4971 | source.identifier.issn |
| Source - eISSN | 1528-0020 | source.identifier.eissn |
| Open Access | No | uulm.OA |
| Community | Universitätsklinikum Ulm | uulm.community |
| WoS | 000384078200013 | uulm.identifier.wos |
| Bibliography | uulm | uulm.bibliographie |
